Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)
20.52
-1.29 (-5.91%)
At close: May 8, 2026
SHE:301408 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 801.07 | - | 999.69 | 1,336 | 482.1 | 284.51 |
Trading Asset Securities | 198 | - | 10 | 12.41 | - | 0.5 |
Cash & Short-Term Investments | 999.07 | - | 1,010 | 1,349 | 482.1 | 285.01 |
Cash Growth | -6.08% | - | -25.14% | 179.76% | 69.16% | 23.37% |
Accounts Receivable | 581.28 | - | 472.6 | 513.14 | 470.77 | 294.32 |
Other Receivables | 56.04 | - | 44.12 | 36.24 | 34.52 | 30.82 |
Receivables | 637.32 | - | 516.73 | 549.38 | 505.29 | 325.14 |
Inventory | 1,089 | - | 863.84 | 772.09 | 545.01 | 436.19 |
Prepaid Expenses | - | - | 15.63 | 8.27 | 2.52 | 4.22 |
Other Current Assets | 257.24 | - | 191.49 | 147.78 | 165.22 | 62.74 |
Total Current Assets | 2,982 | - | 2,597 | 2,826 | 1,700 | 1,113 |
Property, Plant & Equipment | 976.28 | - | 967.8 | 870.15 | 533.42 | 542.53 |
Long-Term Investments | 45.52 | - | 82.2 | 92.81 | 25.45 | 8.92 |
Goodwill | 1,282 | - | 988.37 | 609.31 | 190.06 | 190.06 |
Other Intangible Assets | 63.15 | - | 67.21 | 62.51 | 33 | 8.26 |
Long-Term Deferred Tax Assets | 56.26 | - | 40.65 | 32.83 | 21.92 | 15.17 |
Long-Term Deferred Charges | 82.81 | - | 59.03 | 52.11 | 58.97 | 92.32 |
Other Long-Term Assets | 62.34 | - | 25.48 | 65.74 | 13.23 | 0.5 |
Total Assets | 5,551 | - | 4,828 | 4,612 | 2,576 | 1,971 |
Accounts Payable | 1,750 | - | 1,158 | 1,027 | 698.74 | 468.23 |
Accrued Expenses | 59.4 | - | 140.25 | 99.84 | 101.68 | 79.98 |
Short-Term Debt | 267.26 | - | 316.92 | 513.51 | 340.31 | 150.77 |
Current Portion of Long-Term Debt | 357.43 | - | 116.02 | 10.25 | - | - |
Current Portion of Leases | - | - | 210.44 | 193.64 | 154.24 | 144 |
Current Income Taxes Payable | 66.01 | - | 20.63 | 12.3 | 34.63 | 13.15 |
Current Unearned Revenue | 35.58 | - | 37.11 | 27.06 | 19.41 | 11.25 |
Other Current Liabilities | 112.99 | - | 178.94 | 80.31 | 12.7 | 15.25 |
Total Current Liabilities | 2,649 | - | 2,179 | 1,964 | 1,362 | 882.64 |
Long-Term Debt | 437.15 | - | 358.83 | 331.15 | 18.95 | - |
Long-Term Leases | 209.05 | - | 222.85 | 237.65 | 248.51 | 303.03 |
Long-Term Unearned Revenue | 1.75 | - | 0.81 | 0.91 | - | - |
Long-Term Deferred Tax Liabilities | 6.1 | - | 6.65 | 6.32 | - | - |
Other Long-Term Liabilities | 4.5 | - | - | 95.4 | - | 0.33 |
Total Liabilities | 3,307 | - | 2,768 | 2,635 | 1,629 | 1,186 |
Common Stock | 400.01 | - | 400.01 | 400.01 | 340 | 340 |
Additional Paid-In Capital | 916.8 | - | 977.86 | 1,014 | 194.7 | 192.99 |
Retained Earnings | 859.51 | - | 627.42 | 529.39 | 412.58 | 251.81 |
Total Common Equity | 2,176 | - | 2,005 | 1,944 | 947.28 | 784.8 |
Minority Interest | 67.43 | - | 55.14 | 33 | -0.27 | 0.25 |
Shareholders' Equity | 2,244 | - | 2,060 | 1,977 | 947.01 | 785.05 |
Total Liabilities & Equity | 5,551 | - | 4,828 | 4,612 | 2,576 | 1,971 |
Total Debt | 1,271 | - | 1,225 | 1,286 | 762.02 | 597.8 |
Net Cash (Debt) | -271.83 | - | -215.36 | 62.53 | -279.92 | -312.8 |
Net Cash Per Share | -0.68 | - | -0.53 | 0.16 | -0.82 | -0.94 |
Filing Date Shares Outstanding | 399.92 | 394.56 | 400.01 | 400.01 | 340 | 340 |
Total Common Shares Outstanding | 399.92 | 394.56 | 400.01 | 400.01 | 340 | 340 |
Working Capital | 333.52 | - | 418.84 | 862.52 | 338.42 | 230.65 |
Book Value Per Share | 5.44 | - | 5.01 | 4.86 | 2.79 | 2.31 |
Tangible Book Value | 830.76 | - | 949.71 | 1,272 | 724.22 | 586.49 |
Tangible Book Value Per Share | 2.08 | - | 2.37 | 3.18 | 2.13 | 1.72 |
Buildings | - | - | 219.2 | 238.73 | 23.15 | 23.15 |
Machinery | - | - | 297.24 | 270.16 | 79.38 | 65.74 |
Construction In Progress | 38.73 | - | 168.66 | 61.34 | 32.24 | 0.25 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.